Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 May 1;7(5):e248606.
doi: 10.1001/jamanetworkopen.2024.8606.

Dequalinium Chloride-An Emerging Option in the Sparse Landscape of Bacterial Vaginosis Therapies

Kayla A Carter  1   2 , Susan Tuddenham  3 , Rebecca M Brotman  1   4
Affiliations
Comment

Dequalinium Chloride-An Emerging Option in the Sparse Landscape of Bacterial Vaginosis Therapies

Kayla A Carter et al. JAMA Netw Open. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Tuddenham reported receiving royalties from UpToDate outside the submitted work and participating in research supported by in-kind donation of sexually transmitted infection (STI) test kits to her institution through Hologic. Dr. Brotman reported receiving donation of STI testing kits from Hologic for a research study outside the submitted work. No other disclosures were reported.

Comment on

References

    1. Peebles K, Velloza J, Balkus JE, McClelland RS, Barnabas RV. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019;46(5):304–311. doi:10.1097/OLQ.0000000000000972 - DOI - PubMed
    1. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006;193(11): 1478–1486. doi:10.1086/503780 - DOI - PubMed
    1. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194(5):1283–1289. doi:10.1016/j.ajog.2005.11.041 - DOI - PubMed
    1. Mendling W, Weissenbacher ER, Gerber S, Prasauskas V, Grob P. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch Gynecol Obstet. 2016;293(3):469–484. doi:10.1007/s00404-015-3914-8 - DOI - PMC - PubMed
    1. Weissenbacher ER, Donders G, Unzeitig V, et al.; Fluomizin Study Group. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety. Gynecol Obstet Invest. 2012;73(1):8–15. doi:10.1159/000332398 - DOI - PubMed

Publication types

Substances